For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers and findings from their Pre-Symptomatic Familial ALS (Pre-fALS) study,...
The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in the fields of ALS, frontotemporal dementia (FTD), other...
To help raise awareness about rare diseases, the National Center for Advancing Translation Science (NCATS) hosts an annual ‘Rare Diseases are Not Rare’ challenge. Members of the ALS Center research team participated in this challenge. Please see below to view our...
The ALS Center’s own Michael Benatar MD, PhD spoke on “The Future is Now: ALS Research at the University of Miami” at the 7th 2020 Hope and Help Symposium, hosted by The ALS Association Florida Chapter.
Dr. Michael Benatar, Executive Director of the University of Miami’s ALS Center, gave a webinar about Biomarkers at the 2020 ALSA Advocacy Day. He discussed the importance of biomarkers and how they are essential to developing therapies for patients with...
Recent Comments